Bulletin
Investor Alert

MTBC Inc.

NAS: MTBC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 18, 2020, 4:38 p.m.

/zigman2/quotes/209873871/composite

$

9.50

Change

-0.05 -0.52%

Volume

Volume 410

Quotes are delayed by 20 min

/zigman2/quotes/209873871/composite

Previous close

$ 9.18

$ 9.55

Change

+0.37 +4.03%

Day low

Day high

$9.01

$9.63

Open

52 week low

52 week high

$3.25

$13.40

Open

Insider Actions for MTBC Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/11/2020 Kimberly Grant
General Counsel & Secretary
5,525   Disposition at $9.5 per share. 52,487
08/06/2020 Anne M. Busquet
Director
4,500   Derivative/Non-derivative trans. at $0 per share. 0
08/06/2020 Cameron P. Munter
Director
4,500   Derivative/Non-derivative trans. at $0 per share. 0
08/06/2020 John N. Daly
Director
4,500   Derivative/Non-derivative trans. at $0 per share. 0
08/02/2020 Stephen Andrew Snyder
Chief Executive Officer; Director
3,450   Derivative/Non-derivative trans. at $10.87 per share. 37,501
08/02/2020 A. Hadi Chaudhry
President; Director
2,333   Derivative/Non-derivative trans. at $10.87 per share. 25,359
08/02/2020 Norman Roth
Controller
875   Derivative/Non-derivative trans. at $10.87 per share. 9,511
08/02/2020 Kimberly Grant
General Counsel & Secretary
700   Derivative/Non-derivative trans. at $10.87 per share. 7,609
08/02/2020 Stephen Andrew Snyder
Chief Executive Officer; Director
7,500   Derivative/Non-derivative trans. at $0 per share. 0
08/02/2020 Anne M. Busquet
Director
4,250   Derivative/Non-derivative trans. at $0 per share. 0
08/02/2020 Cameron P. Munter
Director
4,250   Derivative/Non-derivative trans. at $0 per share. 0
08/02/2020 John N. Daly
Director
4,250   Derivative/Non-derivative trans. at $0 per share. 0
08/02/2020 A. Hadi Chaudhry
President; Director
6,667   Derivative/Non-derivative trans. at $0 per share. 0
08/02/2020 Norman Roth
Controller
2,500   Derivative/Non-derivative trans. at $0 per share. 0
08/02/2020 Kimberly Grant
General Counsel & Secretary
2,000   Derivative/Non-derivative trans. at $0 per share. 0
06/29/2020 Stephen Andrew Snyder
Chief Executive Officer; Director
10,000   Derivative/Non-derivative trans. at $8.19 per share. 81,900
06/29/2020 A. Hadi Chaudhry
President; Director
8,750   Derivative/Non-derivative trans. at $8.19 per share. 71,662
06/29/2020 Norman Roth
Controller
1,750   Derivative/Non-derivative trans. at $8.19 per share. 14,332
06/29/2020 Kimberly Grant
General Counsel & Secretary
2,275   Derivative/Non-derivative trans. at $8.19 per share. 18,632
06/29/2020 Stephen Andrew Snyder
Chief Executive Officer; Director
15,000   Gift at $0 per share. 0
06/29/2020 Stephen Andrew Snyder
Chief Executive Officer; Director
25,000   Derivative/Non-derivative trans. at $0 per share. 0
06/29/2020 A. Hadi Chaudhry
President; Director
25,000   Derivative/Non-derivative trans. at $0 per share. 0
06/29/2020 Norman Roth
Controller
5,000   Derivative/Non-derivative trans. at $0 per share. 0
06/29/2020 Kimberly Grant
General Counsel & Secretary
6,500   Derivative/Non-derivative trans. at $0 per share. 0
06/19/2020 Bill Korn
Chief Financial Officer
6,750   Disposition at $8.46 per share. 57,105
06/18/2020 John N. Daly
Director
8,000   Disposition at $7.76 per share. 62,080
06/05/2020 A. Hadi Chaudhry
President; Director
5,000   Disposition at $7.53 per share. 37,650
06/02/2020 Bill Korn
Chief Financial Officer
2,168   Disposition at $7.36 per share. 15,956
05/21/2020 Cameron P. Munter
Director
50,000   Disposition at $6.7 per share. 335,000
05/01/2020 Mahmud Ul Haq
Executive Chairman; Director
5,750   Derivative/Non-derivative trans. at $5.92 per share. 34,040
05/01/2020 Bill Korn
Chief Financial Officer
5,750   Derivative/Non-derivative trans. at $5.92 per share. 34,040
05/01/2020 Mahmud Ul Haq
Executive Chairman; Director
12,500   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Bill Korn
Chief Financial Officer
12,500   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
14 Purchases
10 Sales
106,417
50,658
Last 6 months
16 Purchases
19 Sales
131,417
148,911
Last 12 months
30 Purchases
37 Sales
206,417
359,200

Officers and Executives

Mr. Mahmud Ul Haq
Executive Chairman
Mr. Stephen Andrew Snyder
Chief Executive Officer & Director
Mr. A. Hadi Chaudhry
President & Director
Mr. Bill Korn
Chief Financial Officer
Dr. Jonathan Bertman
Chief Medical Officer
Mr. Alfonso Nardi
Vice President-Strategic Initiatives
Ms. Shruti Patel
President-Telemedicine & Compliance Director
Mr. Mike Cuesta
Chief Marketing Officer
Mr. Wesley Stolp
Executive Vice President-Sales
Mr. Norman Roth
Principal Accounting Officer & Controller
Ms. Kimberly Grant
Secretary & General Counsel
Mr. Lawrence Steven Sharnak
Independent Non-Executive Director
Dr. Cameron P. Munter
Independent Non-Executive Director
Mr. John N. Daly
Independent Non-Executive Director
Ms. Anne M. Busquet
Independent Non-Executive Director
Link to MarketWatch's Slice.